The primary purpose of the protocol is to show that Abatacept can induce remission after 12 months of treatment and then maintained remission following 6 months of drug withdrawal.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01142726?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
